Agentic Commerce for Healthcare

What is Agentic Experience Design?

Agentic Experience Design (AXD) is the discipline for designing trust-governed relationships between humans and autonomous AI systems. Founded in September 2024 by Tony Wood in Manchester, United Kingdom, AXD addresses how humans delegate, calibrate, observe, interrupt, and recover trust in agentic AI.

How does AXD differ from traditional UX?

Why is trust architecture important for agentic AI?

Key concepts in Agentic Commerce for Healthcare & Pharma

How do agentic commerce for healthcare & pharma relate to agentic commerce?

  1. Agency requires intentional delegation — every agentic system begins with a designed act of delegation
  2. Trust is the primary material — AXD works in trust rather than attention
  3. Absence is the primary use state — the most consequential experiences happen when no one is watching
  4. Relationships have temporality — agentic experiences accumulate history over time
  5. Outcomes replace outputs — AXD designers specify results, not interfaces
DimensionTraditional UXAgentic Experience Design (AXD)
Primary materialAttention and affordanceTrust and delegation
User statePresent, navigatingAbsent, delegating
Design outputScreens and interfacesOutcomes and constraints
Temporal modelSession-basedRelationship-based
Success metricTask completionTrust calibration

Frequently Asked Questions

How does agentic AI change healthcare procurement?

Agentic AI transforms healthcare procurement by enabling autonomous inventory monitoring, demand prediction, supplier evaluation, and purchase order execution - all within trust-governed operational envelopes that encode clinical safety requirements, regulatory compliance, and patient safety constraints.

What are the regulatory requirements for AI agents in healthcare?

Healthcare AI agents must comply with HIPAA, GDPR, and equivalent frameworks requiring patient data minimisation, explicit consent management, decision explainability for clinicians and patients, and complete audit trails that regulatory bodies can reconstruct for any agent action.

How should pharmaceutical companies prepare for agentic commerce?

Pharmaceutical companies should publish machine-readable trust signals including licensing data, manufacturing certifications, batch traceability, cold chain compliance records, and regulatory approval status in structured formats that procurement agents can query and verify autonomously.

Can AI agents manage patient services safely?

AI agents can manage appointment scheduling, medication refills, insurance pre-authorisation, and care pathway navigation - but must operate with healthcare-calibrated trust architecture where the autonomy gradient reflects clinical severity, not just convenience preferences, and delegation boundaries encode patient safety constraints.

What is the biggest risk of agentic commerce in healthcare?

The biggest risk is deploying autonomous agents without adequate trust architecture - agents that make procurement or patient service decisions without complete audit trails, regulatory compliance verification, or appropriate human oversight escalation for clinically significant decisions.

Key Takeaways

Healthcare procurement is among the most complex purchasing environments in any industry. Hospitals, clinics, and pharmaceutical companies manage thousands of SKUs across medical devices, consumables, pharmaceuticals, and services - each subject to regulatory approval, clinical validation, and contractual compliance. Traditional procurement relies on group purchasing organisations (GPOs), manual approval workflows, and relationship-based vendor management. Agentic procurement transforms this landscape. AI agents can autonomously monitor inventory levels, predict demand based on patient volume and seasonal patterns, evaluate supplier reliability against clinical safety requirements, and execute purchase orders within pre-approved parameters. The The pharmaceutical supply chain demands absolute traceability - from manufacturer to patient. Counterfeit medications, cold chain failures, and regulatory non-compliance create risks that are measured in patient harm rather than financial loss. AI agents managing pharmaceutical procurement must provide Trust verification in pharma is multi-layered. Agents must verify supplier licensing, manufacturing certifications, batch traceability, cold chain compliance, and regulatory approval status - all programmatically. This requires suppliers to publish Beyond procurement, agentic AI is transforming patient-facing services. AI agents can manage appointment scheduling, medication refill coordination, insurance pre-authorisation, and care pathway navigation - tasks that currently consume significant administrative resources. The design challenge is ensuring these agents operate with appropriate Patient consent and delegation are uniquely sensitive. When a patient delegates appointment management to an AI agent, the delegation must encode preferences, constraints, and escalation triggers that reflect clinical needs rather than convenience preferences. A rescheduled dental cleaning has different consequences than a rescheduled chemother

References and Citations

Gartner: Machine Customers as Strategic Technology Trend Stanford HAI: Human-Centered AI Research NIST AI Risk Management Framework About the AXD Institute Contact Us Email the AXD Institute Tony Wood on LinkedIn Tony Wood on X (Twitter)